A successful and independent Corporation

Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the corporate vision, the organisation and the company's history.


India

Our focus globally is on helping patients and improving quality of life for millions of people who rely on us. In India, Boehringer  Ingelheim is one the fastest growing multinational pharmaceutical. It was set up in 2003 and currently ranks 8th among MNCs.  

Presently, Boehringer Ingelheim India operates through its business areas of Human Pharmaceuticals, Animal Health and Clinical operations.

Partnerships and alliances: Boehringer Ingelheim India and Lupin Ltd have a strategic alliance for diabetes in India. This partnership shows our commitment towards addressing challenges in diabetes management by providing broader access to innovative medicine. Through its research and scientific excellence, Boehringer Ingelheim India will continue to introduce innovative products to address the unmet medical needs.

Awards & Recognitions -

2017

  • Dr H R Nanji Memorial OPPI Award Marketing Excellence 2017 for Trajenta
  • AWACS Awards in Marketing Excellence 2017 Brand of the year for Trajenta
  • AWACS Awards in Marketing Excellence 2017 Brand of the year for Jardiance
  • BI India has been recognized as one of the Top 20 Companies with Great Managers by People Business in partnership with Economic Times
  • BI has been recognised as 2017 Working Mother and AVTAR 100 Best Companies for women in India

2016

  • Boehringer Ingelheim India received the "The Company of the Year" Award by AIOCD.
  • Boehringer Ingelheim India received Pharmaceutical Brand of the Year (Marketing Excellence Award:Trajenta) by AIOCD
  • Boehringer Ingelheim India received Marketing Excellence Award (New Introduction: Jardiance) by AIOCD

2015

  • Boehringer Ingelheim India received the "Emerging Company of the Year" Award by AIOCD.
  • Boehringer Ingelheim India received the "Sales Force effectiveness" Award by OPPI.

2013​

  • Boehringer Ingelheim India received Pharmaceutical Brand of the Year award (new lanch:Trajenta) by Frost & Sullivan
  • Boehringer Ingelheim India received Marketing Excellence Award by OPPI.

 

Annoucements

Resignation of Mr. Thomas Wilmesmeier 
Boehringer Ingelheim India Pvt. Ltd. announced that Mr. Thomas Wilmesmeier has resigned from the Board of Directors of the Company w. e. f. 14/9/2017.